← FDA Drug Approvals (Drugs@FDA)
OXYBUTYNIN CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX PHARMS · Approved 2006-11-09
Drug application
- FDA Application #
ANDA076745- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXYBUTYNIN CHLORIDE
- Generic name
- Oxybutynin Chloride
- Active ingredients
- OXYBUTYNIN CHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- IMPAX PHARMS
- First approval
- 2006-11-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown